On the recordSeptember 29, 2020
Your company has made more than $34 billion--$34 billion--from Copaxone but it reported to the committee that it has spent two percent of that on R&D expenditures for Copaxone patients.
Source
congress.govEditor's note · Context
Raskin highlights the disparity between profits and R&D spending on a drug.
Share
More from Jamie Raskin
Jun 26, 2026
They are determined to compensate Trump’s private street-fighting militia and create 1,600 MAGA Millionaires with our money.
Aug 12, 2026
Specifically, we have information that a Florida man living temporarily in Washington, D.C., may have illegally bulldozed and destroyed the East Wing of the White House, causing hundreds of millions of dollars of damage there.
Other voices in this conversation
